These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Distinct cell responses to substrates consisting of poly(ε-caprolactone) and poly(propylene fumarate) in the presence or absence of cross-links. Wang K; Cai L; Hao F; Xu X; Cui M; Wang S Biomacromolecules; 2010 Oct; 11(10):2748-59. PubMed ID: 20822174 [TBL] [Abstract][Full Text] [Related]
24. Coaxial PCL/PVA electrospun nanofibers: osseointegration enhancer and controlled drug release device. Song W; Yu X; Markel DC; Shi T; Ren W Biofabrication; 2013 Sep; 5(3):035006. PubMed ID: 23799653 [TBL] [Abstract][Full Text] [Related]
25. Bioactivity improvement of poly(epsilon-caprolactone) membrane with the addition of nanofibrous bioactive glass. Lee HH; Yu HS; Jang JH; Kim HW Acta Biomater; 2008 May; 4(3):622-9. PubMed ID: 18171636 [TBL] [Abstract][Full Text] [Related]
26. Galactose grafting on poly(ε-caprolactone) substrates for tissue engineering: a preliminary study. Russo L; Russo T; Battocchio C; Taraballi F; Gloria A; D'Amora U; De Santis R; Polzonetti G; Nicotra F; Ambrosio L; Cipolla L Carbohydr Res; 2015 Mar; 405():39-46. PubMed ID: 25498202 [TBL] [Abstract][Full Text] [Related]
27. Surface engineering of polycaprolactone by biomacromolecules and their blood compatibility. Khandwekar AP; Patil DP; Shouche Y; Doble M J Biomater Appl; 2011 Aug; 26(2):227-52. PubMed ID: 20511382 [TBL] [Abstract][Full Text] [Related]
28. Characterization of the surface biocompatibility of the electrospun PCL-collagen nanofibers using fibroblasts. Zhang YZ; Venugopal J; Huang ZM; Lim CT; Ramakrishna S Biomacromolecules; 2005; 6(5):2583-9. PubMed ID: 16153095 [TBL] [Abstract][Full Text] [Related]
29. Batch preparation of electrospun polycaprolactone/chitosan/aloe vera blended nanofiber membranes for novel wound dressing. Yin J; Xu L Int J Biol Macromol; 2020 Oct; 160():352-363. PubMed ID: 32470578 [TBL] [Abstract][Full Text] [Related]
30. Preparation of poly(epsilon-caprolactone)/continuous bioglass fibre composite using monomer transfer moulding for bone implant. Jiang G; Evans ME; Jones IA; Rudd CD; Scotchford CA; Walker GS Biomaterials; 2005 May; 26(15):2281-8. PubMed ID: 15585230 [TBL] [Abstract][Full Text] [Related]
31. Effects of different sterilization methods on the physico-chemical and bioresponsive properties of plasma-treated polycaprolactone films. Ghobeira R; Philips C; Declercq H; Cools P; De Geyter N; Cornelissen R; Morent R Biomed Mater; 2017 Jan; 12(1):015017. PubMed ID: 28117304 [TBL] [Abstract][Full Text] [Related]
32. Development of novel electrically conductive scaffold based on hyperbranched polyester and polythiophene for tissue engineering applications. Jaymand M; Sarvari R; Abbaszadeh P; Massoumi B; Eskandani M; Beygi-Khosrowshahi Y J Biomed Mater Res A; 2016 Nov; 104(11):2673-84. PubMed ID: 27325453 [TBL] [Abstract][Full Text] [Related]
33. Electrospun poly(epsilon-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering. Ghasemi-Mobarakeh L; Prabhakaran MP; Morshed M; Nasr-Esfahani MH; Ramakrishna S Biomaterials; 2008 Dec; 29(34):4532-9. PubMed ID: 18757094 [TBL] [Abstract][Full Text] [Related]
34. Improved osteogenic differentiation of human marrow stromal cells cultured on ion-induced chemically structured poly-epsilon-caprolactone. Marletta G; Ciapetti G; Satriano C; Perut F; Salerno M; Baldini N Biomaterials; 2007 Feb; 28(6):1132-40. PubMed ID: 17118444 [TBL] [Abstract][Full Text] [Related]
35. Highly roughened polycaprolactone surfaces using oxygen plasma-etching and in vitro mineralization for bone tissue regeneration: fabrication, characterization, and cellular activities. Kim Y; Kim G Colloids Surf B Biointerfaces; 2015 Jan; 125():181-9. PubMed ID: 25486326 [TBL] [Abstract][Full Text] [Related]
36. Surface modification of poly(epsilon-caprolactone) using a dielectric barrier discharge in atmospheric pressure glow discharge mode. Little U; Buchanan F; Harkin-Jones E; Graham B; Fox B; Boyd A; Meenan B; Dickson G Acta Biomater; 2009 Jul; 5(6):2025-32. PubMed ID: 19269907 [TBL] [Abstract][Full Text] [Related]
37. Poly(ε-caprolactone)/graphene oxide biocomposites: mechanical properties and bioactivity. Wan C; Chen B Biomed Mater; 2011 Oct; 6(5):055010. PubMed ID: 21921319 [TBL] [Abstract][Full Text] [Related]
39. The physical properties and response of osteoblasts to solution cast films of PLGA doped polycaprolactone. Tang ZG; Callaghan JT; Hunt JA Biomaterials; 2005 Nov; 26(33):6618-24. PubMed ID: 15935466 [TBL] [Abstract][Full Text] [Related]
40. Fabrication of a biocomposite reinforced with hydrophilic eggshell proteins. Kim G; Min T; Park SA; Kim WD; Koh YH Biomed Mater; 2007 Dec; 2(4):250-6. PubMed ID: 18458482 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]